礼来减肥药Foundayo在英国获批，进军欧洲市场

摘要与判断

礼来公司的减肥药Foundayo首次获得美国以外的销售批准，将在英国市场与诺和诺德的Wegovy展开直接竞争。这标志着欧洲市场迎来了第二款GLP-1减肥药丸，打破了诺和诺德在当地的独家局面，将显著加剧全球减肥药市场的双头竞争格局。

Topics

引用和原文

• Eli Lilly has won its first approval to sell its weight-loss drug Foundayo outside the U.S
• 原文链接

Trace

Raw Item

raw_fbbac05825e748b2

Processed Item

processed_d93ddbbaa9814c54

Source

source_x_cnbc

Cluster

查看所属簇

LLM Logs

llm_3b500e4fe1e04e57, llm_b64499fc168c4fb5, llm_f64450708e16489c

Coze Loop

c86ddff392bb6fd62f16997563278a1c